BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed LTRN catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:86eb7339f91b1610d98e@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:LTRN P2 readout (est.): HARMONIC
DESCRIPTION:A Study of LP-300 With Carboplatin and Pemetrexed in Never Smok
 ers With Advanced Lung Adenocarcinoma\nNCT05456256 | PHASE2 | RECRUITING |
  sponsor: Lantern Pharma Inc.\nPrimary completion date (ESTIMATED)\; top-l
 ine results usually follow later.\nDate precision: month (shown on the fir
 st day)\nTicker LTRN (confidence 0.9)\nSource: https://clinicaltrials.gov/
 study/NCT05456256\nScheduling/reference data from public records\; dates c
 an move. Not investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT05456256
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
